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Effects of Low Doses of Quinpirole on Production of 50 kHz Vocalizations in Wistar Rats 
Rats emit two distinct types of ultrasonic vocalizations in adulthood: 22 kHz (aversive 
situation), and 50 kHz calls (appetitive situation). The present project is focussed on 
' pharmacological studies of 50 kHz vocalizations. The 50 kHz calls are elicited from 
dopaminergic activation in the meso limbic pathway and are emitted in such appetitive situations 
as social contact(s), sexual encounters, food reward, etc. Eighty-five male rats were 
stereotaxically implanted with bilateral guide cannulae in the nucleus accumbens shell (A= 9.7, 
L= 1.2, V= 6.7). Quinpirole, a D2/D3 dopaminergic agonist, was injected in low doses to the 
nucleus accumbens shell in an attempt to elicit 50 kHz vocalizations. A dose response was 
obtained for the low dose range of quinpirole for six doses: 0.025 Jlg, 0.06 Jlg, 0.12 Jlg, 0.25 Jlg, 
0.5 Jlg, and 1.0 Jlg. It was found that only application of the 0.25 Jlg dose of quinpirole and the 7 
Jlg dose of amphetamine (positive control) significantly increased the total number of 50 kHz 
calls (p < 0.006 and p < 0.004 respectively); and particularly significantly increased the 
frequency modulated type of these calls (p < 0.01, and p < 0.006 respectively). In a double 
injection procedure, the dose of 0.25 Jlg quinpirole was antagonized with raclopride (D2 
antagonist) or U99194A maleate (D3 antagonist) in an attempt to antagonize the response. The 
0.25 Jlg dose of quinpirole was successfully antagonized by pre-treatment with an equimolar 
dose ofU99194A maleate (p < 0.008) but not with raclopride. The 7 Jlg amphetamine response 
was also antagonized with an equimolar dose of raclopride. Based on these results, it seems that 
low doses of quinpirole, particularly the 0.25 Jlg dose, are capable of increasing 50 kHz 
vocalizations in rats and do so by activation of the D3 dopamine receptor. This is not a biphasic 
response as seen with locomotor studies. Also noteworthy is the increase in frequency modulated 
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Animal communication mechanisms have been well studied over the years and it is a 
complex subject due to the mostly species-specific nature of animal communication (Portfors, 
2007). What remains consistent across the myriad of ways in which animals communicate is the 
concept of the signal, whatever modality that may be. Signals have a communicative purpose, 
i.e., are of adaptive value to the animal sending and/or receiving the signal (Brudzynski, 2005). 
Animals need to be able to communicate quickly and reliably regarding basic survival of the 
species, i.e., approaching predators, or in social situations, i.e., establishment of hierarchal 
systems (Bradbury & Vehrencamp, 1998; Brudzynski, 2005). This type of information may be 
termed "biologically significant stimuli or cues" and allows the receiver of the relevant 
information to better predict their current environment and to act accordingly (Brudzynski, 
2005). 
One ofthe most effective forms of communication (with respect to the communicative 
speed between sender and receiver) across anurans, avians, and mammals is the method of sound 
production to convey information (Bradbury & Vehrencamp, 1998). The term used for this type 
of communication across species is bioacoustic signalling. In mammals, vocal sound production 
is accomplished by a combination of respiratory, laryngeal, and supra-laryngeal control and by 
adjusting that control to homeostatic needs allowing for a variety of sounds to be produced and 
emitted (JUrgens & Ploog, 1981). These sounds can be produced in the human audible range (20 
Hz - 20 kHz), and also in the ultrasonic range of frequency which is above 20 kHz (Sales & Pye, 
1974; Brudzynski, 2005, Portfors, 2007). 
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Rat Communication - Ultrasonic Vocalizations 
Rats, like most other mammals, have anti-predator defensive adaptations to protect 
themselves from the large number of animals that prey on them. Although rats do communicate 
to other species through squeals in the 2 - 4 kHz range (in an attempt to ward off an attack), their 
main method of bioacoustic signalling within their own species is through ultrasonic 
vocalizations (Blanchard, et aI., 1991; Brudzynski, 2005; Portfors, 2007; Brudzynski, 2009). 
These ultrasonic vocalizations (USVs) are emitted on the whistle principle: the rat makes an 
inspiration, the larynx is stabilized, and the vocal folds are slightly separated so as to produce 
sound in the ultrasonic range, in a similar way to that of a human whistle (Brudzynski, 2005; 
Brudzynski, 2009). 
The USVs are a useful means of communication for rats as they have a nocturnal lifestyle 
and live in colonies and are very social animals (Blanchard, et aI., 1991; Wohr, & Schwarting, 
2007; Brudzynski, 2005). Since most of their predatory species do not hear in the ultrasonic 
range, these calls likely go undetected while having a meaningful message for conspecifics 
(Blanchard, et aI., 1991). However, the most important function the USV s appear to serve is in 
the non-defensive social domain (Brudzynski, 2009). Rats are extremely gregarious animals and 
if given the choice, would rather spend time with conspecifics than in isolation or time spent 
with inanimate objects (Wohr & Schwarting, 2007). Studies in which rats were de-vocalized 
prior to social meetings showed deficits in their social encounters and these deficits were able to 
be improved by the playback of natural USVs (White & Barfield, 1987, 1989, & 1990). 
The ultrasonic calls used by rats have distinctive acoustic features that may offer a way of 
quantifying the magnitude of the sign meaning within that call (Portfors, 2007; Brudzynski, 
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2005). For example, the decibel level ofthe call could indicate the urgency of the message, 
much like a human raising their voice. Also, it is speculated that the higher the number of 
vocalizations emitted within a certain time period, the greater the magnitude of response in the 
receivers. USVs n:ay encode only one meaning (monosemic calls), or they may convey more 
than one message to the recipient (polysemic calls). Biologically, it is more beneficial for rats to 
encode more than one meaning in their USV signals (Brudzynski, 2005). For instance, these calls 
may serve as a means of localization allowing the sender and receiver to assume proximity; they 
inform conspecifics of predators and aversive situations which promotes freezing behaviours or 
escape. Also, these USV s serve an emotional and social function allowing rats to communicate 
their overall state to conspecifics, and to organize social approach or avoidance (Brudzynski, 
2005; Portfors, 2007; Burgdorf, et aI., 2008). There are many possibilities pertaining to the 
function of these calls. As seen in many studies, emitted USVs evoke behavioural activation and 
a change in behaviour of the rat recipient. Behavioural responses indicate that these calls serve a 
communicative purpose and can elicit an appetitive or aversive response from the recipient even 
though the USVs differ depending on age, the subject's current state, and environmental factors 
(Wohr, & Schwarting, 2007; Portfors, 2007; Burgdorf, et aI., 2008; Wohr et aI., 2008; 
Brudzynski, 2009). There are three distinct types of ultrasonic vocalization emitted by rats: pup 
isolation calls, 22 kHz calls, and 50 kHz calls. 
Rat pup isolation calls 
The first of the ultrasonic vocalizations are observed as pup isolation calls. These calls 
vary in frequency and duration and have a drastic fluctuation in sonographic structure (Sales & 
Pye, 1974; Sales, 1979a; Brudzynski, 2005; Portfors, 2007). Calls may vary from 20-160 ms in 
14 
duration, 10-120 kHz in frequency range, and may have a bandwidth anywhere from 2 to 180 
kHz (Brudzynski, et aI.; 1999). Even though there is great variation in call frequency, studies 
have shown that the frequency sweeps (U or hump shaped) within these calls are most likely 
where the message is encoded (Sales, 1979a; Brudzynski, et aI., 1999; Hashimoto, et al., 2004; 
Brudzynski, 2005; Portfors, 2007), as well as the total number of these calls emitted by pups 
(Sales, 1979a; Brunelli, et al., 1994). The message within these calls is directed toward the 
mother, dam (Sales, & Pye, 1974; Portfors, 2007). When pup isolation calls are emitted, retrieval 
behaviour in the dams as well as nest building activity is elicited. The number of calls emitted by 
the pups directly correlates to the intensity of the searching and retrieval behaviour in the dams 
(Sales, 1979a; Brunelli, et al., 1994). As to pups, survival is near impossible without the dam's 
care and attendance. These pup "distress" calls are extremely important to ensure that pups stay 
within the nest and that they receive the care and warmth they need to survive. Thus, these calls 
are critical for survival (Sales, 1979a; Brudzynski, 2005). 
Isolation calls can be elicited by removing a pup from its litter and/or nest (Wahr, & 
Schwarting, 2007; Brudzynski, 2005; 2009), which results in a drop in temperature, a lack of 
tactile stimulation, and nutritional state (Sales, 1979a), all of which cause the pups to "alert" their 
mother. The anatomical structures involved in the production of the rat pup isolation calls 
include the thalamus, hypothalamus, amygdala, nucleus accumbens, preoptic area, septum, and 
the anterior cingulate cortex projecting to the periaqueductal grey (Hofer, 1996). Indeed, the 
subcortical regions of the brain are responsible for the emission of isolation calls seen in rat pups 
as ablation of the cortex does not attenuate isolation calls when cold stimulation is applied to 
simulate removal from the litter (Middlemis-Brown, et aI., 2005). The rat pup isolation calls are 
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only seen up to day 16-20 of age (Sales & Pye, 1974; Sales, 1979a; Kehoe, et al., 2001; Portfors, 
2007), after which the two distinct types of adult USV s are observed: 22 kHz calls and 50 kHz 
calls. 
22 kHz Vocalizations 
One type of ultrasonic vocalization used by the adult rat is the 22 kHz call. These calls 
are emitted during aversive situations or in the anticipation of an aversive encounter: foot shock 
(Borta, et aI., 2006; Portfors, 2007), presence of a predator (Blanchard, et al., 1991; Brudzynski, 
& Ociepa, 1992; Portfors, 2007), during the post-ejaculatory period (Barfield & Geyer, 1972; 
Lore, et aI., 1976; Sales, 1979a; Blanchard et aI., 1991; Van der Poel & Miczek, 1991; 
Brudzynski, & Ociepia, 1992), during inter-male aggression (Sales, 1979; Takeuchi, & 
Kawashima, 1986; Portfors, 2007), after startling noises (Kaltwasser, 1991; Portfors, 2007), 
rough handling (Brudzynski & Ociepa, 1992), or any situation that induces an overall negative 
affective state (Knutson, et aI., 2002). These calls are also known as "alarm" calls because they 
can signal danger to the entire colony. It has been hypothesized that these calls signal internal 
states that are homologous to the human emotions of anxiety and sadness; and anxiolytics 
attenuate the 22 kHz call response (Wohr, & Schwarting, 2007; Wohr, et aI., 2008). However, 
this anxiety and subsequent emission of 22 kHz calling is due to potential danger not the direct 
painful event itself (Blanchard et aI., 1991; Van der Poel & Miczek, 1991; Jourdan, et aI., 2002; 
Brudzynski, 2009). For example, rats responded with higher numbers of22 kHz calls when a 
foot shock was unavoidable compared to the same intensity of shock, but avoidable. (Kikusui, et 
aI., 2003; Borta, et aI., 2006; Portfors, 2007). 
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The acoustic characteristics of these calls are quite different from the rat pup isolation 
calls. 22 kHz calls have a relatively stable frequency (20-30 kHz) with minimal modulation (1-6 
kHz bandwidth; Sales, & Pye, 1974; Brudzynski et aI., 1993; Brudzynski & Pniak, 2002; 
Brudzynski, 2005 ~ 2009; Portfors, 2007). There is a short version ofthis call (lasting 20-300 ms) 
and a long version (300-3400 ms; Sales, & Pye, 1974; Brudzynski et aI., 1993; Brudzynski & 
Pniak, 2002; Brudzynski, 2005; 2009). The call duration of this type of call is clearly quite 
variable and it is speculated that this parameter, along with the total number emitted, is where the 
information coding lies (Brudzynski et aI., 1993; Brudzynski & Pniak, 2002; Brudzynski, 2005; 
2009). 
These alarm calls are generated by release of acetylcholine in the medial cholinoceptive 
strip in the brain that originates from the laterodorsal tegmental nucleus and innervates the 
periventricular areas, anterior hypothalamic preoptic area, bed nucleus of the stria terminalis, and 
the lateral septal nucleus (Brudzynski, 1994; Brudzynski & Barnabi, 1996; Brudzynski, 2001; 
2007; 2009). The endogenous release of acetylcholine in this system can be mimicked by 
application of muscarinic cholinergic agonists (i.e., carbachol) into the post-synaptic fields, 
while anticholinergic agents (i.e., atropine or scopolamine) applied to the same areas decrease 
the amount of22 kHz calls emitted (Brudzynski, 1994; 2001; 2005; 2009). 
The 22 kHz vocalizations serve a communicative purpose because they are capable of 
eliciting behavioural change in conspecifics. For example, when natural and even simulated 22 
kHz calls were played back to rats, these calls elicited freezing, avoidance behaviours, or bursts 
oflocomotion; all consistent with defensive behaviours (Brudzynski, et aI., 1993; Brudzynski & 
Chiu, 1995; Wohr & Schwarting, 2007; Portfors, 2007). Similarly, Blanchard et aI., (1991) 
demonstrated that when alarm calls were emitted by a dominant rat in response to a predator in 
an open area outside of a colony burrow, the entire colony responded by hiding, demonstrating 
defensive behaviours, and propagating the message by further emitting 22 kHz calls for hours. 
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The 22 kHz calls also have relevance in other social contexts. During inter-male 
aggression, these calls were found to be associated with submissive postures and the occurrence 
of the dominant attacks decreased as the submissive 22 kHz calls increased (Sales, & Pye, 1974; 
Lehman & Adams, 1977; Sales, 1979a; Portfors, 2007; Burgdorf, et aI., 2008). Also, individually 
reared rats with a subsequent lack of social interaction tend to emit fewer of the 22 kHz calls in 
response to aversive stimuli than rats reared in paired housing with a same sex conspecific 
(Inagaki, et aI., 2005). 
50 kHz Vocalizations 
Mutually exclusive to, and opposite in biological function to the 22 kHz alarm call is the 
50 kHz appetitive ultrasonic vocalization. This separation in signal meaning by frequency range 
ensures that the call receiver recognizes the message within the signal and can then respond 
accordingly (Brudzynski, 2007). This type of call is also emitted in adulthood and in adolescence 
and is observed during rough-and-tumble play (Panksepp, 1981; Knutson, et aI., 1998; Portfors, 
2007; Burgdorf, et aI., 2008), in anticipation of social contact (Knutson et aI., 1998; Brudzynski 
& Pniak, 2002; Wohr, et aI., 2008; Brudzynski, 2009), handling CBrudzynski & Ociepa,1992), 
mating (Barfield & Geyer, 1972; Sales & Pye, 1974; Sales, 1979a; White & Barfield, 1987; 
1989; 1990; Kaltwasser, 1990; Portfors, 2007), in response to an anaesthetized conspecific 
(Blanchard, et aI., 2003), rewarding brain stimulation (Burgdorf et aI., 2000), or in response to an 
addictive drug (Brudzynski, 2009). Rats also emit such calls when "tickled" by a skilled 
experimenter in a playful way resembling rat rough-and-tumble play (Knutson et al., 1998; 
Panksepp et aI., 2000; Burgdorf & Panksepp, 2001; Portfors, 2007). In general, 50 kHz 
vocalizations are ,emitted during appetitive situations and are a postulated index of the rat's 
positive affective state (Burgdorf et al., 2000; Knutson et aI., 2002). 
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This type of adult vocalization is initiated by dopaminergic stimulation of the mesolimbic 
pathway (lkemoto & Panksepp, 1999; Burgdorf et al., 2007; Burgdorf et al., 2008; Brudzynski, 
2009). This pathway originates in the ventral tegmental area (VTA) and innervates the nucleus 
accumbens shell and other forebrain structures (Burgdorf et al., 2001; Thompson et aI., 2006; 
Brudzynski, 2007). Dopaminergic agonists such as amphetamine and apomorphine injected 
directly into the nucleus accumbens shell mimick the endogenous dopamine release from the 
VTA and elicit 50 kHz vocalizations (Burgdorf et aI., 2001; Thompson et aI., 2006; Brudzynski, 
2007). Likewise, intraaccumbens injection of dopaminergic antagonists attenuate the 50 kHz 
calling response (Thompson, et aI., 2006; Burgdorf, et aI., 2007; Brudzynski, 2007). 
These calls are characterized by a short duration of 3-65 ms, a frequency range of 35-75 
kHz, and a variable bandwidth due to variation in frequency (Sales, 1972a; Sales, & Pye, 1974; 
Blanchard et al., 1991; Brudzynski & Pniak, 2002; Brudzynski, 2007; 2009). Due to many 
variable acoustic parameters, it is possible to code the information in the signal in a variety of 
ways (Portfors, 2007; W5hr, et aI., 2008); however, it has been suggested that the meaning of 
this type of call is encoded in the number of emitted calls per unit time and/or in the frequency 
modulation (Brudzynski, 2005). In previous studies, it was found that in positive social 
situations, rats emitted significantly more 50 kHz calls than in socially irrelevant ones; further 
suggesting that the message is likely encoded in the number of calls emitted per unit time 
(Brudzynski,2005). 
Two Types of 50 kHz Vocalizations 
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Recently, researchers have been able to distinguish two major types of 50 kHz calls: 
constant frequency (flat) calls and frequency-modulated calls (step calls with trills; Burgdorf et 
al., 2007, Wehr, et al., 2008; Burgdorf et aI., 2008). In the past, all types of 50 kHz calls have 
been labelled as the appetitive or positive ("happy") rat calls. However, more recent research has 
been showing that there is a shorter, constant frequency call (flat call) that was interpreted as 
having a social co-ordinating function during inter-male aggression or as a means of expression 
of social ambivalence (Wehr, et aI., 2008; Burgdorf, et aI., 2008). In resident-intruder paradigms, 
the intruder was the source of the flat 50 kHz calls suggesting that the rat was showing its 
submissiveness when entering the resident's home cage in an attempt to minimize attacks (Wehr, 
et aI., 2008). Perhaps the calls were emitted as if to say, "approaching in a friendly manner" to 
the rat in their home cage (Brudzynski, & Pniak, 2002). There has been evidence of some 
approach behaviour elicited from playback of flat 50 kHz calls, yet the rats more readily 
approached the source of the frequency modulated 50 kHz calls (Wehr, & Schwarting, 2007). 
Although the flat 50 kHz call may serve a purpose other than an unambivalent positive 
affective state, the 50 kHz frequency modulated calls do consistently correlate with an appetitive 
state in the rat (Burgdorf, et aI., 2008; Brudzynski, 2009). For example, rats would choose 
playback of the frequency modulated 50 kHz call over the flat variety at significance levels 
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(Burgdorf, et aI., 2008). Also, it has been demonstrated that these calls induce approach 
behaviour from rats receiving playback of 50 kHz calls from both sexual, and non-sexual 
situations, i.e., rough-and-tumble play (Wohr & Schwarting, 2007; Burgdorf, et al., 2007; 2008). 
Even juvenile rats would prefer to be near adult rats that emitted high levels of frequency 
modulated 50 kHz vocalizations and would avoid those emitting 22 kHz calls (panksepp et al., 
2002; reviewed in Burgdorf et aI., 2008). Previous experiments demonstrating that 50 kHz calls 
indicate a positive social experience, (i.e., in anticipation of social contact and play), are still 
correct in their interpretation of 50 kHz calls as being indicative of a positive state in the animal; 
however, newer research indicates that frequency modulated 50 kHz calls are more effective in 
displaying the positive affective state than the flat 50 kHz call (Knutson et aI., 1998; Bialy et aI. , 
2000; Brudzynski & Pniak, 2002; Burgdorf, et aI., 2007). 
Panksepp & Burgdorf (2000; 2003) have proposed that the frequency modulated 50 kHz 
calls may represent an archaic form of human laughter. These calls are seen during 
heterospecific and conspecific play and are emitted during times of positive affect much like 
when humans laugh (Panksepp & Burgdorf, 2000; 2003; Burgdorf, et aI., 2008). However, this 
does not mean that the calls the rats emit are exactly laughter, but rather that they are a 
counterpart of human laughter (Bruzynski, 2009). Research into the exact meaning and 
behavioural consequences of the various types of frequency modulated 50 kHz calls is the 
direction in which much rat vocalization studies are going. 
Since 50 kHz calls have been seen to reliably and effectively exhibit positive emotional 
states in the rat, they have received much experimental attention (Wohr & Schwarting, 2007), 
and could possibly be of use in studying emotional disorders as potential models of emotional 
21 
disorders in humans. Also, because it has been well documented, as mentioned previously, that 
50 kHz calls are emitted by activity of the mesolimbic pathway, these calls may serve as a 
unique measure in studying natural reward pathways (Wohr & Schwarting, 2007; Wohr, et aI., 
2008). Thus, man~ studies are focussing on the functional role of dopamine receptor subtypes in 
50 kHz vocalization behaviour. 
Dopaminergic Receptors - D2 and D3 Subtypes 
Dopamine (DA) is a monoamine neurotransmitter in the central nervous system (CNS; 
Gehlert et al., 1992; Neve & Neve, 1997; Kebabian et al., 1997; Webster, 2001; Cooper, et aI., 
2003; Julien, 2005). In the CNS, dopamine is involved in motor regulation, reinforcement, 
olfaction, mood, concentration, hormone control, and hypoxic drive (Julien, 2005). The overall 
concentration ofDA in different brain regions is as follows: the striatum (10 /lg/g), nucleus 
accumbens (5 /lg/g), olfactory tubercle (6 /lg/g), and the cortex (0.1 /lg/g) (Webster, 2001). 
Through various cloning studies, five different varieties (or subtypes) of dopamine 
receptors have been discovered (Kruk & Pycock, 1991; Gehlert et aI., 1992; Neve & Neve, 1997; 
Kebabian et aI., 1997; Webster, 2001; Von Bohlen, et aI., 2002; Cooper et aI., 2003; Julien, 
2005). There are two families of receptors with various subtypes. The D 1 receptor family 
includes the DI and Ds receptors. The D2 receptor family includes the D2, D3, and D4 receptors. 
Each family is characterized by different pharmacological and biochemical properties although 
subtypes within the families are somewhat related in function (Kruk & Pycock, 1991; Gehlert et 
aI., 1992; Neve & Neve, 1997; Kebabian et aI., 1997; Webster, 2001; Von Bohlen, et al., 2002; 
Cooper et al., 2003; Julien, 2005). All types of dopaminergic receptors have seven membrane 
spanning regions and are metabotropic - have interactions with G-proteins to exert their effects 
(Neve & Neve, 1997; Kebabian et aI., 1997; Von Bohlen, et aI., 2002; Cooper, et al., 2003; 
Julien, 2005). 
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The D2 receptor subtype relative abundance in the brain (in decreasing concentration) is 
as follows: striatum, limbic regions, spinal cord, hypothalamus, and hippocampus (Webster, 
2001). There are long and short isoforms of this receptor although both seem to exert the same 
effects when the receptor is activated (Gehlert et aI., 1992; Neve & Neve, 1997; Kebabian et aI., 
1997; Webster, 2001; Von Bohlen, et al., 2002). Dl and D2 receptors have been implicated in the 
stimulatory effects seen within the nigrostriatal pathway and also in the mesolimbic pathway in 
eliciting 50 kHz vocalizations. D2 receptors have been studied more so than the D3 subtypes and 
this may be due to the more abundant variety of antagonists and agonists available for studying 
the D2 receptor. 
The D3 receptor has structural and pharmacological similarities with the D2 receptor 
because they are in the same family of dopamine receptors. Both subtypes inhibit adenylate 
cyclase; however, the exact G-proteins involved for each subtype may vary (Neve & Neve, 1997; 
Kebabian et aI., 1997; Webster, 2001). D3 receptors are distributed in the basal forebrain, the 
olfactory tubercule, nucleus accumbens, and islands of Calleja, (Sokoloff et aI., 1990; Gehlert, et 
aI., 1992; Neve & Neve 1997; Webster, 2001; Von Bohlen, et aI., 2002); however, they are 
found mainly in the mesolimbic pathway which is associated with motivational and emotional 
functions (Sokoloff et aI., 1990; Gehlert et aI., 1992; Neve & Neve, 1997; Cooper, et aI., 2003). 
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Due to a lack of selective specificity of D3 agonists and their antagonists, there is nothing known 
about its role in the production of 50 kHz vocalizations. 
There are post-synaptic and pre-synaptic forms (autoreceptors) seen for both D2 and D3 
DA receptors, and. there has been an abundance of mRNA found in the rat brain for the D2 and 
D3 varieties of dopaminergic post-synaptic receptors in the nucleus accumbens (Sokoloff et aI., 
1990; Gehret et aI., 1992; Elsworth & Roth, 1997; Webster, 2001; Cooper, et aI., 2003). By 
activating post-synaptic receptors, there is an enhancement in DA transmission while blocking 
post-synaptic receptors subsequently attenuates DA transmission. By activating DA 
autoreceptors, a negative feedback loop is initiated that will decrease synthesis and release and 
possibly decrease the firing rate of the pre-synaptic neuron. Likewise, if a DA autoreceptor is 
blocked, DA synthesis and release is increased (Elsworth & Roth, 1997; Von Bohlen, et aI., 
2002; Cooper, et al., 2003). The autoreceptors, like postsynaptic receptors, desensitize in 
response to DA agonists and become supersensitive after repeated DA antagonist application 
(Elsworth & Roth, 1997; Von Bohlen, et aI., 2002; Cooper et aI., 2003). However, ifthere are 
minimal amounts of DA in the synapse or the frequency of release is too low, autoreceptors are 
not activated; suggesting there is an autoreceptor threshold for activation (Webster, 2001). It 
seems that these DA autoreceptors are most common in striatal and mesolimbic circuits and are 
most often of the D2 and D3 receptor subtype (Elsworth & Roth, 1997; Webster, 2001). 
Mesolimbic Dopamine System 
Dopamine has three main pathways in the brain: mesocortical/mesolimbic, nigrostriatal, 
and tuberoinfundibular (Kruk: & Pycock, 1991; Webster, 2001; Cooper, et al., 2003; Julien, 
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2005). The mesolimbic pathway is involved in reward reinforcement, and emotion; the 
nigrostriatal pathway is heavily involved in motor regulation and control; the tuberoinfundibular 
pathway is involved in the regulation of hormone release. The pathway focussed on for this 
thesis is the mesol~mbic pathway as it is involved in emotional behaviour (50 kHz calls are an 
index of positive affective states), and it is capable of stimulating the 50 kHz call response after 
direct DA agonist application. The dopamine neurons originate from the ventral tegmental area 
(VTA) and innervate mostly the nucleus accumbens shell. The mesocortical pathway is 
connected by furtherprojections to forebrain areas (Kruk & Pycock, 1991; Neve & Neve, 1997; 
Webster, 2001; Cooper, et aI., 2003; Julien, 2005). An enhancement in dopamine transmission in 
the meso limbic system is linked with reinforcing effects of psycho stimulant drugs like 
amphetamine and apomorphine (Ranaldi & Beninger, 1994; Von Bohlen, et aI., 2002; Cooper, et 
aI., 2003). The 50 kHz vocalizations, previously discussed, are emitted following dopamine 
release in the nucleus accumbens shell as part of the mesolimbic dopamine system (Ikemoto & 
Panksepp, 1999; Burgdorf et al., 2007; Burgdorf et aI., 2008; Brudzynski, 2009). Also 
noteworthy is that the mesoaccumbal dopaminergic system responds to DA antagonists, DA 
agonists, and responds to monoamine oxidase (MAO) inhibitors. The DA nerve terminals 
contain synthesis modulating autoreceptors, and have high-affinity DA transporters (Gehlert et 
aI., 1992; Neve & Neve, 1997; Cooper, et aI., 2003). The ability to respond to the 
aforementioned types of pharmacological agents suggests that manipulation of the system and 
resulting meso limbic response is possible through drug application to the mesolimbic dopamine 
system. 
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It is a basic principle of phannacology that the phannacological, physiological, or 
behavioural effects induced by a drug follow from the interaction of ligands with receptors (Neve 
& Neve, 1997; Julien, 2005). It is also a general rule of psychopharmacology that drugs do not 
create any unique artificial effects; they merely modulate normal neuronal functioning -
mimicking, or antagonizing the actions of a specific neurotransmitter, i.e., dopamine (Julien, 
2005). Binding accompanied by drug-induced mimicry or facilitation of neurotransmitter action 
is an agonistic action. Drug occupation of a receptor that is not accompanied by 
neurotransmitter-like activation and blocks the access of the neurotransmitter to the receptor is 
an antagonistic action (Kruk & Pycock, 1991; Neve & Neve, 1997; Julien, 2005). 
Quinpirole 
The drug chosen to be used as a means of manipulating the mesolimbic system 
(mimicking DA release in the nucleus accumbens shell from VTA activation), with respect to 50 
kHz vocalization behaviour is quinpirole. Quinpirole is a dopaminergic D21D3 receptor agonist 
(Koller et aI., 1987; Mogenson & Wu, 1991a; 1991b; Szechtman et aI., 1994; Neve & Neve, 
1997). It has been reported as having a higher affinity for the D2 receptor than the D3 receptor 
(Kruk & Pycock, 1991; Kebabian et aI., 1997). However, some suggest that it has a higher 
affinity for the D3 receptor than the D2 receptor (Oehlert et aI., 1992; Neve & Neve, 1997; 
Cooper, et al., 2003). Nonetheless, most research reported using this drug, has been with respect 
to locomotion in rats whether it be via systemic injection or intracerebral injection. 
Repeated treatment with quinpirole produces a sensitized behavioural response in rats 
manifested as an increase in locomotor activity (Szechtman, et aI., 1994; Neve & Neve, 1997; 
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Lomanowska, et ai. 2004; Culver et aI., 2008). This sensitization is a common response with 
most dopaminergic psychostimulants that seems to be caused by heightened meso limbic system 
activation (Wu et al., 1993; Szechtman et aI., 1994; Culver, et al., 2008). Particular interest has 
been placed in th~ quinpirole sensitized rat. Through repeated intermittent administration of 
quinpirole, rats become sensitized and engage in compulsive "checking" behaviours akin to 
obsessive compulsive disorder (OCD) in humans; quinpirole sensitization has been suggested as 
a possible animal model for OCD (Culver, et al., 2008). 
Quinpirole also elicits changes in rat locomotor behaviour after acute administration. 
These effects are generally biphasic resulting in the initial inhibition of behaviour followed by 
excitiation (Szechtman et al., 1994; Culver, et aI., 2008). At lower doses (0.1 mg/kg), quinpirole 
produces locomotor inhibition (Koller et al., 1987; Mogenson & Wu, 1991a), whereas higher 
doses display this biphasic effect (Lomanowska, et al., 2004; Culver, et aI., 2008). As the 
number of injections increases (sensitization), the latency of hyperkinesia onset decreases 
(Sullivan, et al., 1998; Lomanowska, et aI., 2004). It has been suggested that this inhibition effect 
seen after acute quinpirole application is likely due to autoreceptor activation (Mogenson & Wu, 
1991a; 1991b; Wu et aI., 1993; Neve & Neve, 1997; Lomanowska, et aI., 2004); there is much 
evidence in general of the dopamine autoreceptor activation by quinpirole (Koller, et aI., 1987; 
Mogenson & Wu, 1991a; 1991b; Wu et al., 1993). 
After acute administration of quinpirole, the treatment increased dopamine tissue levels 
in the nucleus accumbens and in the right prefrontal cortex (Sullivan et al. 1998). Sullivan, et al., 
(1998) reported that in a post mortem study completed by Chen, et al., (1987), it was found that 
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15 min after a 1 mglkg injection of quinpirole, dopamine stores were increased by 39% in the 
nucleus accumbens, 23% in the caudate, and 19% in the frontal cortex. There were also 
decreases in accumbens and caudate DOP AC levels suggesting a decreased turnover of 
dopamine, which could be the cause of the increased locomotor behaviour elicited after the 
initial decrease in activity. Also, after sensitization treatment, quinpirole increased the density of 
D2 dopamine receptors in the nucleus accumbens, but not in the striatum (Culver, et aI., 2008). 
This change in receptor density could correlate with an increased sensitivity of dopamine 
autoreceptors (Lomanowska, et aI., 2004; Culver, et aI., 2008). It is therefore evident that 
quinpirole has an effect on the dopaminergic system pre- and post-synaptically; however, the 
exact mechanism of action is unknown at this time. 
Amphetamine 
Amphetamine is a well-known and widely used psycho stimulant that increases the 
release of dopamine from pre-synaptic nerve terminals enabling the released DA to act on post-
synaptic terminals (Mogenson & Wu, 1991b; Wu et aI., 1993; Webster, 2001; Von Bohlen et aI., 
2002; Cooper et aI., 2003; Julien, 2005; Fleckenstein et aI., 2007). Through action in the CNS, 
amphetamine produces behavioural effects of tremor, restlessness, increased motor activity, 
agitation, insomnia, and a loss of appetite (Julien, 2005). Amphetamine-increased dopaminergic 
activity at postsynaptic terminals results in increased locomotor behaviour and sometimes 
stereotyped behaviour when given in high doses (Mogenson & Wu, 1991b; Szechtman et al., 
1994; Julien, 2005). At lower doses, amphetamine elevates arousal and causes an overall 
increase in positive mood and speech behaviour (Julien, 2005). Amphetamine also increases 50 
kHz calling rates when directly injected into the nucleus accumbens shell of rats (Burgdorf et aI., 
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2001; Thompson et aI., 2006; Brudzynski, 2007; Ahrens et aI., 2009). Particularly, the numbers 
of frequency modulated call types are elevated (Burgdorf et aI., 2001; Ahrens et aI., 2009). 
Amphetamine, similarly to cocaine, is taken up by the pre-synaptic dopamine transporter 
(DAT) into pre-synaptic nerve terminals where it causes the release of dopamine from vesicles 
(Kruk & Pycock, 1991; Webster, 2001; Julien, 2005; Fleckenstein, et aI., 2007). Amphetamine is 
a MAO inhibitor and thus stops the breakdown of DA released from vesicles. DA then travels 
down a concentration gradient out of the pre-synaptic cell into the synaptic cleft. Alternatively, 
amphetamine may enter the pre-synaptic cell by means of exchange diffusion with DA (Kruk & 
Pycock, 1991; Webster, 2001; Julien, 2005). In the present study, amphetamine is used as the 
positive control for quinpirole dopaminergic stimulation as it is well documented that 
amphetamine elicits 50 kHz vocalizations from the accumbens even though the molecular 
mechanism of action of the two drugs may differ. 
Rationale and Hypotheses 
Previous research completed in the lab here at Brock University (St. Pierre, 2008) 
suggested that intraaccumbens injection of quinpirole significantly increased the number of 50 
kHz calls beyond those elicited by isotonic saline. However, this result was seen in the high dose 
range (from 0.5 - 20 Ilg in 0.2 ilL), and the dose response had not been fully completed with 
respect to the low dose range. The goal of this thesis was to explore the low dose range (0.025-
1.0 Ilg in 0.2 ilL), and determine if intraaccumbens injection of quinpirole in low doses would 
also significantly increase 50 kHz vocalizations. It may also be expected that quinpirole may 
have an atypical dose-response curve. Also, as previously mentioned with regard to locomotor 
studies, quinpirole's acute injection effects are biphasic (initial decrease in activity followed by 
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an increase in activity; Szechtman, et aI., 1994; Culver, et aI., 2008). It was of interest to 
determine if there would be biphasic effects with vocalization behaviour after direct application 
of quinpirole to the accumbens shell. 
The findings in the higher dose range (St. Pierre, 2008) were consistent with literature 
stating that dopaminergic agonists injected directly to the nucleus accumbens shell elicit 50 kHz 
vocalizations (Webster, 2001; Burgdorf, et aI., 2001; Thompson et al., 2006; Ahrens, et aI., 
2009). To my knowledge, this study is the first research done with quinpirole and its effects on 
50 kHz calls in rats in the low range of doses. Thus, it was imperative to complete, in detail, the 
dose response to be able to explain quinpirole's overall effects on 50 kHz calls. 
Along with looking at the possible increase of 50 kHz calls after low dose quinpirole 
application, it was of interest to explore the sonographic properties of the calls emitted as well. 
As aforementioned, much of the ultrasonic vocalization field is working toward the behavioural 
meaning and consequence of the different subtypes of 50 kHz calls. Was quinpirole increasing 
all types of 50 kHz calls proportionally or was there a specific type of call being increased, 
particularly frequency modulated calls as happens after amphetamine administration. 
The specific hypotheses constructed were: 
1) It was expected that the low dose range of quinpirole would not significantly increase 50 
kHz calls beyond saline levels. Work completed by St.Pierre (2008) showed the 0.5 Ilg 
dose of quinpirole to be ineffective in stimulating the 50 kHz call behaviour. There was 
no evidence to suggest that the low dose range could stimulate behavioural activation. 
2) The standard call parameters and sonographic properties of the calls were not 
hypothesized to be affected by quinpirole. 
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3) Raclopride antagonism at the higher dose level of quinpirole was successful (St. Pierre, 
2008). Therefore, raclopride (D2 receptor) antagonism was also planned and a successful 
attenuation of any quinpirole effect, if seen, was expected. 
4) Since quinpirole also has affinity for the D3 subtype of dopamine receptor, a D3 
antagonist (U99194A - maleate) was planned to be used for comparison with the D2 
antagonist (raclopride), but not expected to antagonize the response because of previous 
work completed by st. Pierre (2008) where raclopride successfully antagonized the 50 
kHz call response at high doses of quinpirole. 
5) If any increase in calls was observed after quinpirole application, it was hypothesized that 
the frequency modulated variety of calls would be increased as well, as is observed after 
application of amphetamine. 
Significance of the Study 
As previously reported, 50 kHz calls are elicited after dopaminergic agonist application 
in the mesolimbic pathway. This pathway has long been implicated in drug reward, natural 
reward, emotionality, and motivation (Kruk & Pycock, 1991; Neve & Neve, 1997; Webster, 
2001; Cooper, et aI., 2003; Julien, 2005). Also, 50 kHz vocalizations (especially the frequency 
modulated type) have been found to be an index of positive affect in the rat and are elicited 
through stimulation of the meso limbic pathway (Burgdorf et al., 2001; Thompson et aI., 2006; 
Brudzynski, 2007). Perhaps 50 kHz vocalizations can help elucidate some aspect of human 
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emotionality and possibly addiction. Human emotional and motivational disorders such as 
depression and anxiety are steadily rising to the second cause of financial burden to the health 
care system in North America (World Health Organization, 2010). If a suitable animal model of 
human emotional ,disorder(s) is possible through measurements of ultrasonic vocalizations, it is 
of much importance to explore and hopefully discover ways in which these calls are elicited, 
produced, and what receptors are specifically responsible so that drugs with an affinity to these 
receptors can be developed and tested. 
Aside from emotional human disorders, human motor disorders such as Parkinson's 
disease (PD) have been utilizing the method of US V analysis to help study the communicative 
symptoms in rat models ofPD (Ciucci, et aI., 2007; Ciucci, et al., 2010). The USV deficits 
observed in the rat models, (i.e., decreased volume, and degradation of pitch/tone, and 
segmentation of calls), are also those observed for humans suffering from this debilitating 
disorder (Ciucci, et aI., 2007; Ciucci, et aI., 2010). Through the study of the vocal aspect ofthe 
disease, possible treatments may come available. USV s are a valid and extremely useful tool 
when looking to study and possibly assuage some of the symptoms of human disease whether it 
be emotional or vocal communication disorders. 
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Materials and Methods 
Experimental Subjects 
The subjects used throughout this thesis were 85 adult male Wistar rats weighing 
approximately 220-230g upon arrival to Brock University from Charles River (Montreal, QC, 
Canada). Rats were pair housed in standard polycarbonate cages (dimensions: 460 mm x 250 
mm x 195 mm) with com cob bedding, one black polyvinyl tube for hiding, and two sheets of 
paper towel. Rats were given approximately one week to acclimate to the facility. The cages 
underwent a thrice weekly cleaning schedule and received standard rat chow and water available 
ad libitum, on a 12/12hr light/dark cycle. All experimental procedures were done in accordance 
with the guidelines set by the Canadian Council on Animal Care and were approved by the 
Animal Care and Use Committee at Brock University. 
Stereotaxic Surgeries 
At the time of surgery, all rats weighed approximately 250-340g. Animals were 
anesthetized by an intraperitoneal injection ofketamine hydrochloride (40 mglkg i.p., Katalean, 
MTC Pharmaceuticals, Cambridge, Ont. Canada) and xylazine hydrochloride (6 mg/kg i.p., 
Rompun, Bayvet Div. Chemargo Ltd., Etobicoke, ON, CA) and were placed in the Kopf 
stereotaxic apparatus (David Kopf Instruments, Tujunga, CA) after shaving the surgical site. 
Once properly mounted to the apparatus, the surgical site was scrubbed with an iodine and 
detergent solution. This was followed by a cleaning with isopropyl alcohol and finally, a pure 
iodine solution was administered to the site. A small incision was made in the scalp, and the 
periosteum was scraped away revealing the skull bone sutures. The apparatus was then calibrated 
and set to the appropriate co-ordinates for the nucleus accumbens shell according to the Paxinos 
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& Watson, (1986) stereotaxic atlas. Small holes were drilled in the skull and chronic 23 gauge 
stainless steel guide cannulae were implanted bilaterally to the nucleus accumbens shell. The co-
ordinates used for the nucleus accumbens shell measured from lambda were A = 9.7 mm, L = 1.2 
mm, V = 6.7 mm and were placed 1 mm above the intended injection site (Paxinos, & Watson, 
1986). Following cannulae implantation, stainless steel jeweller's screws were used along with 
methyl methylacrylate resin (Perm, Hygenic Corporation of Canada Inc., St. Catharines, ON, 
CA) to secure the implant(s). Finally, the incision was sutured around the acrylic resin. After 
surgery, the openings of the cannulae were plugged with stainless steel wires and rats received a 
subcutaneous injection (s.c.) of an analgesic, ketoprofen (2 mg/kg s.c., Anafen, Merial Canada 
Inc., Morgan Baie d'Urfe, QC, CA) and an antibiotic, enrofloxacin (11 mglkg s.c., Baytril, Bayer 
Inc., Toronto, ON, CA), and were allowed to recover for 7 days in isolation housing conditions. 
For more information on the stereotaxic cannulae implantation surgeries, see Pellegrino & 
Cushman (1971), & Myers, (1971). 
Intracerebral (Intraaccumbens) Single Injections and Drugs 
Groups of rats underwent surgery each within a few days to minimize the differences in 
the time of survival and possibility of infection. As a result, injections were organized and 
carried out in approximately groups of fifteen rats at a time. The first three groups of rats 
underwent the dose response injections (quantifying the drug-receptor interaction; Julien, 2005), 
which were done unilaterally with dosages of 0.025 f.lg, 0.06 f.lg, 0.12 f.lg, 0.25 f.lg, 0.5 f.lg, and 
1.0 f.lg quinpirole hydrochloride (Sigma-Aldrich Canada Ltd., Oakville, ON, CA) and isotonic 
saline (vehicle control) injected through the right guide cannula (see Appendix A for injection 
schedule). A 7 f.lg dose ofD-amphetamine sulfate (Dextroamphetamine, Sigma-Aldrich Canada 
Ltd., Oakville, ON, CA) was injected unilaterally through the left guide cannula as a positive 
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control. Results of injections were recorded immediately after intracerebral drug injection. Dose 
response groups also underwent an additional recording 35-40 minutes after the initial injection 
without any additional injection. The rats spent the time lapse between recordings in their home 
cage inside the colony room. This was completed to determine if the effects of the drug were 
immediate, long-lasting, or delayed. 
All injections were completed with a Hamilton constant rate micro-syringe (CR-700-20) 
at a rate of3.3 x 10-6 mLis via polyethylene tubing connected to a stainless steel 30 gauge 
injection cannula for a total injection volume of 0.2 /JL per injection. For all groups, injection 
sessions were arranged with a three to four day lapse between injections. This was done to 
minimize any possible drug interaction or sensitization, and to allow the receptors to recover. 
Intracerebral (Intraaccumbens) Double Injections and Drugs 
Similarly, an additional three groups of approximately fifteen rats were used to complete 
the double injection antagonist portion ofthis thesis (see Appendix A for injection schedules). 
The first of the three groups received unilateral injections ofD-amphetamine sulfate 
(Dextroamphetamine, Sigma-Aldrich Canada Ltd., Oakville, ON, CA) pre-treated with either 
isotonic saline or an equimolar dose of rac10pride L-tartrate (Sigma-RBI, Oakville, ON, CA), a 
dopamine D2 receptor antagonist. Rac10pride has a K<J value of -1.7 nM to the D2 receptor and a 
Kd value of - 2.3 nM for the D3 receptor (Seeman, et aI., 2006). These injections were completed 
using the right guide cannula to avoid the sites into which the amphetamine was injected on the 
left side of the brain in the dose response injections. On the left side of the brain, the quinpirole 
hydrochloride (Sigma-Aldrich Canada Ltd., Oakville, ON, CA) injections were administered at a 
dose of 0.25 /Jg as this was found to be the optimal dose from the low dose response data 
35 
obtained in this study. These injections were pre-treated with isotonic saline or raclopride L-
tartrate (Sigma-RBI, Oakville, ON, CA) in an equimolar dose to the 0.25 Ilg dose of quinpirole. 
The final two double injection groups were injected in an identical manner with full 
counterbalancing across cannulae and drug condition. These rats received injections ofO.25llg 
quinpirole hydrochloride (Sigma-Aldrich Canada Ltd., Oakville, ON, CA) pre-treated with either 
isotonic saline, or an equimolar dose ofU-99194A maleate (Sigma-Aldrich Canada Ltd., 
Oakville, ON, CA), a dopamine D3 receptor antagonist. U99194A maleate has a Kd value of-
2281 nM for the D2 receptor and a Kd value of -223 nM to the D3 receptor (Seeman, et aI., 
2006). 
Vocalization Recording 
Vocalization recording for all groups commenced approximately one minute after 
removal of the injection cannula as 50 kHz calls started to be emitted at that time. All recordings 
took place in a clean polycarbonate cage (dimensions: 220 mm x 200 mm x 190 mm) with fresh 
com cob bedding and a wire grate lid. The recording condenser microphone (model 
CMI6/CMPA, Avisoft Bioacoustics, Berlin, Germany) was mounted to this lid approximately 
200 mm away from the rat, and was aimed directly into the cage. This method of vocalization 
recording is more reliable and accurate in preserving all aspects of the call and maintaining the 
call in its undivided form compared to past techniques using a bat detector, which utilized 
frequency division (Burgdorf et aI., 2008; Brudzynski, 2009). After each recording session, the 
recording cage was replaced. This was done to minimize scent cues from other rats as these have 
been demonstrated to elicit 50 kHz calling in anticipation of social contact (Brudzynski & Pniak, 
2002; Wahr et aI., 2008). All recordings were taken for a total time of 10 minutes per injection 
at a 500,000 Hz sampling rate in 16 bit format using Avisoft Bioacoustic Software (Avisoft 
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Recorder NI-DAQMX, Berlin, Germany) and stored on the hard drive of a PC computer (Dell 
Precision 390); the files were permanently stored on DVDs for re-analysis. Dose response groups 
underwent an additional recording 3S-40 minutes after the initial injection. The time lapse 
between recordings was spent in their home cage in the colony room. This delay was to 
determine if the effects of quinpirole were immediate, long-lasting, or delayed. 
Histological Localization of Injection Sites 
Following injection(s) completion, rats were euthanized with an overdose ofEuthanyl 
(240 mg/mL sodium pentobarbital, Euthanyl, Vetoquinol N-A, Lavaltrie, QC, CA), an 
approximate 0.S-0.8 mL intraperitoneal injection. When euthanasia was complete, brains were 
transcardially perfused with 10% formalin solution to fix the brain before extraction 
(approximately SO-60 mL of 10% formalin per rat). Brains were manually extracted and 
individually placed in 10% formalin solution for a minimum of 2 days before sectioning. 
Fixed brains were removed from formalin, rinsed with water, and blocked to isolate the 
cannulae tracts. Brains were mounted to the stage of a freezing microtome (Cryo-Histomat, 
Hacker Instruments and Industries, Fairfield, NJ) with Tissue Tek compound (Miles Laboratories 
Inc., Naperville, IL, USA), and the dorsal surface was angled toward the blade. Brains were 
sectioned to a thickness of 40-S0J.lm. After sectioning, brains were mounted on labelled 
polylysinated microscope slides by floating the slices onto the slide in a distilled water bath. 
They were then allowed to dry for 12-24 hours before staining. 
The prepared sections were stained using a modified Nissl staining technique according 
to the Rucker-Koithan procedure with a thionine stain (Windle, et aI., 1943; Skinner, 1971). The 
Nissl bodies, nucleoli, necrotic tissue, and intracerebral injection sites stained dark blue while the 
37 
fibre tracts stained a lighter blue. After the staining procedure was complete, slides were 
coverslipped using Permount glue (Fisher Scientific, Suwanee, GA, USA). Once given time to 
dry (approximately 24 hours), the slides were used to localize the cannulae tracts and injection 
sites. The middle point of the injection site and not the base of the guide cannulae tracts were the 
target for localization. This was done using a projection light microscope and the coronal 
sections from the rat brain atlas by Paxinos & Watson (1986). 
Acoustic Analysis of 50 kHz Vocalizations 
Rats were eliminated from data analysis if their control saline levels were 5 times higher 
or more than the average baseline level for the group. In these rats, there was minimal room for 
pharmacological effects to be observed. Also, there are some environmental factors that can 
influence these calls and are difficult to control for; for example, the conditioned response to the 
experimenter, and handling itself. Rats seen to be emitting 50 kHz calls due to approach or 
handling by the experimenter were also removed from analysis. Rats were also eliminated from 
analysis if their cannulae localization were found to be outside of the nucleus accumbens. No 
more than 1-2 extreme rats were removed per group before analysis, and these rats were deleted 
across all comparisons. 
All acoustic files were analyzed in the A visoft SASlab Pro program for the number of 50 
kHz calls present within ten minutes along with the corresponding parameters: bandwidth 
(maximum minus minimum frequency), peak frequency, and call duration. Also observed and 
recorded were the sonographic variations in calls within the 50 kHz group of calls. Calls were 
sub-categorized into flat, step+trill, and FM other (frequency modulated other) call types (see 
Figure 20 for examples). Calls were considered flat if the frequency was relatively unchanging 
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and the bandwidth did not vary more than 10 kHz from the mean frequency (see Figure 20 A). 
Step calls resemble a rapid step up in frequency while trill calls resemble 2-6 sine waves 
fluctuations in frequency; in some cases, the step and trill call types could be seen in 
combination (see Figure 20 A, B & C). The step and trill calls are not as commonly observed, so 
they were grouped together as one subtype. Finally, FM other calls were defined as any other call 
varying in frequency that does not resemble a step or a trill type call (see Figure 20 D). For 
example, a sharp increase/decrease, sweeping type modulations, or any other type of frequency 
modulation. All acoustic analyses were completed by the experimenter who was not blind to 
experimental drug condition. However, with the call type and call parameters criterion, bias in 
this manner was not an issue. 
Statistical Analyses 
All calls incorporated into statistical analysis met the accepted standard parameters for a 50 
kHz vocalization (Sales, 1972a; Blanchard et aI., 1991; Brudzynski & Pniak, 2002; Brudzynski, 
2005; 2007). Statistical analyses were completed using SPSS (SPSS software, SPSS Inc., 
Chicago, IL). The inter-individual variability (distribution in calling) in the data did not allow for 
standard parametric tests, thus, all statistics performed were repeated measures non-parametric 
Friedman ANOV As followed by paired Wilcoxon Signed Ranks Tests. 
Results 
Dose Response Injections 
Intraaccumbens injections of six doses of quinpirole (0.025 Ilg, 0.06 Ilg, 0.12 Ilg, 0.25 
Ilg, 0.5 Ilg, and 1.0 Ilg), revealed an inverted V-shape dose response relationship with the 
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optimal low dose of quinpirole being 0.25 Ilg (peak of inverted V-shape). This dose of 0.25 Ilg of 
quinpirole significantly increased the number of 50 kHz calls above saline baseline levels (i (3, 
15) = 10.53, p= .015; Z= 2.73, P < .006); see Figure 1. All remaining doses ofquinpirole failed 
to elicit significantly more 50 kHz calls than the saline controls. A similar increase in the 50 kHz 
call response was found after intracerebral injection of71lg of amphetamine (Z= 2.84, P < .004); 
see Figure 1. These results indicate that a low dose of quinpirole is sufficient to elicit the 50 kHz 
calling response after intraaccumbens injection in rats, much like the positive control of 
amphetamine but in a very narrow dose-range revealed by a single dose of 0.25 Ilg. This 
response was not accidental and was reproducible in all other experiments with antagonists. 
Delayed Quinpirole Response 
As previously mentioned, additional vocalization recordings were conducted 35-40 
minutes after the scheduled injection and the first recording session. In all cases (other than 
saline), a trend of a decrease in calls was observed during each delayed recording when 
compared to the initial recording session (see Figure 3). There was a significant decrease in 50 
kHz calling in delayed recording when compared to the initial recording session for 0.25 Ilg of 
quinpirole (i (7,15) = 20.75, P = .004; Z = 2.61, P < .009). Likewise, there was a significant 
decrease in 50 kHz calls over time for 7 Ilg amphetamine (Z = 1.93, P < .05). These results 
indicate that the 50 kHz call response is sensitive to these dopamine agonists immediately after 
intraaccumbens application and does not increase over time; this effect is not delayed and it 
disappeared over a 40 minute time period (see Figure 3). 
Raclopride (D2 reeeptor) Antagonism 
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In an attempt to antagonize both the quinpirole and amphetamine increase in 50 kHz call 
responses, an interesting result was observed (see Figure 4). As expected and as documented in 
previous literature (Burgdorf, et al., 2001), 7 Ilg of amphetamine increased 50 kHz calls beyond 
saline levels (t (2, 10) = 5.90, p = .05; Z = 2.35, p < .05; see Figure 4). Also consistent with 
literature (Thompson, et aI., 2006), is the antagonism of the amphetamine response by raclopride, 
a D2 antagonist. Raclopride decreased 50 kHz calls more than four times when injected as a pre-
treatment to 7 Ilg amphetamine (did not reach the significance level due to variability within 
data; Z = 1.79, p < .07). However, when raclopride was injected as a pre-treatment to a 0.25 Ilg 
quinpirole injection, it was unsuccessful in significantly decreasing 50 kHz calls (Z = 1.07, p < 
.24; see Figure 4). These results suggest that amphetamine increases 50 kHz calls through action 
at the D2 dopamine receptor, whereas quinpirole is exerting its effects through another 
mechanism at low doses. This finding gave rise to the following section of this thesis. 
U-99J94A Maleate (D3 receptor) Antagonism 
Two groups of rats were used to explore the possibility that a D3 receptor antagonist may 
antagonize the 0.25 Ilg quinpirole-induced response. The selective D3 receptor antagonist 
U99194A maleate did indeed significantly decrease the 50 kHz call response elicited by 0.25 Ilg 
of quinpirole (t (3, 23) = 7.96, p = .047; Z = 2.66, p < .008; see Figure 5), suggesting 
involvement of D3 dopamine receptors. 
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Call Parameters 
For every call recorded, the parameters of call bandwidth, single call duration, and peak 
frequency were also analyzed. The peak frequency values were consistent with those in the 
literature (within 37-70 kHz; Sales, 1972a; Blanchard et aI., 1991; Brudzynski & Pniak, 2002; 
Brudzynski, 2009). There were no significant differences in mean peak frequency among drug 
conditions in both dose response and double injection antagonism groups (see Figures 6,8, & 
11). Thus, the call frequency was not affected by dopaminergic agonist or by dopaminergic 
antagonist. 
Likewise, the call duration was measured for every call in each drug condition and group. 
There was no difference in call duration among any of the drug conditions regardless of single or 
double injection (see Figures 7, 10, & 12). This call parameter was also within the usual range 
for a 50 kHz call type (3 - 65 ms; Sales, 1972a; Blanchard et aI., 1991; Brudzynski & Pniak, 
2002; Brudzynski, 2009). Similar to peak frequency, mean call duration was unaffected by 
dopamine agonist or antagonist. 
When analyzing bandwidth values, there was an effect of drug group (see Figure 9). 
When comparing a double injection of isotonic saline to a pre-treatment of saline followed by an 
injection of 0.25 Ilg quinpirole, the mean call bandwidth was significantly increased (Z = 2.52, p 
< 0.02). When comparing pre-treatment of saline and raclopride followed by injection of 
amphetamine, raclopride pre-treatment significantly decreased mean call bandwidth (Z = 2.31, p 
< 0.03). All other groups and drug conditions failed to reach any significance values (see Figures 
6 & 11), and the mean bandwidth values were again within the usual range for a 50 kHz call type 
(Sales, 1972a; Blanchard et al., 1991; Brudzynski & Pniak, 2002; Brudzynski, 2009). From these 
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results, it appears that bandwidth is increased by dopamine agonist, and decreased by dopamine 
antagonist. 
Sonographic Structure and Sub-categorization 
When recording call parameters, the sonographic structure of each call was obtained as 
well. The sonographic structures were sub-categorized into 3 distinct categories: flat, step + trill, 
and FM other (frequency modulated other). See Figure 20 for visual examples of sub-categories. 
In dose response groups (see Figure 13), the 0.25 Ilg dose of quinpirole and the 7 Ilg dose of 
amphetamine both significantly increased the number of flat (X2 (3, 15) = 8.21, P = .042; Z = 
2.17, P < .03, and Z = 2.58, P < .01 respectively), step + trill (i (3, 15) = 15.27, p = .002; Z = 
2.87, P < .004, and Z = 2.53, P < .011 respectively), and FM other (i (3, 15) = 14.65, P = .002; Z 
= 2.48, P < .013, and Z = 2.77, p < .006 respectively) type of calls. It is apparent that both 
dopaminergic agonists were capable of increasing all types of 50 kHz vocalization. This finding 
supports the overall increase in 50 kHz calls observed in dose response data. 
The D2 antagonist-treated group showed an increase in frequency modulated other calls 
(FM other) after injection of saline followed by 0.25 Ilg quinpirole (X2 (5, 10) = 20.28, p = .001; 
Z = 2.68, p < .008; see Figure 14). There was also an increase in FM other calls after injection of 
saline followed by 7 Ilg amphetamine (Z = 2.21, p < 0.03). Intere~ingly, when pre-treatment of 
rac10pride was followed by an injection of 0.25 Ilg quinpirole, there was still a significant 
increase in FM other type calls (Z = 1.98, P < 0.05); see Figure 14. This effect was not observed 
when rac10pride injection was followed by an injection of amphetamine (Z = 1.45, P < .15; see 
Figure 14). As previously described, the amphetamine induced call response was decreased with 
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a D2 antagonist pre-treatment; it appears that the frequency-modulated calling response was also 
attenuated by D2 antagonist pre-treatment. 
Finally, the sub-categorization of calls obtained within the D3 antagonist-treated group 
was analyzed (see ,Figure 15). As already observed, the 0.25 J!g dose of quinpirole significantly 
increased both step + trill (i (3, 24) = 12.40, P = .006; Z = 2.29, P < .023), and FM other call 
type varieties (i (3, 24) = 8.18, P = .042; Z= 2.61, P < .01). Pre-treatment with the D3 antagonist 
U99194A maleate attenuated both frequency modulated types of calls as there was no longer a 
significant increase in that call type (see Figure 15). This observation further supports the 
assumption that low doses of quinpirole are acting at the D3 receptor sub-type and antagonize 50 
kHz vocalizations. 
Localization of Injection Sites 
After all scheduled intracerebral injections were complete, rat brains were used to 
analyze the location of the injections. From the histological preparations, the injection sites were 
mapped on coronal sections from the rat brain atlas by Paxinos & Watson (1986; see Figures 16 
& 17). All injection sites for both dose response and double injection groups were within the 
nucleus accumbens at co-ordinates of 10.7 - 9.7 mm from lambda. When mapping the 0.25 J!g 
quinpirole response on the injection sites localized (see Figure 18), there was a trend for the 
nucleus accumbens shell to give the highest number of 50 kHz call responses when compared to 
the nucleus accumbens core, or even the border of the shell. Similarly, when mapping the 7 J!g 
amphetamine responses to nucleus accumbens localization, the nucleus accumbens shell appears 
to be the most effective area in eliciting 50 kHz vocalizations (see Figure 19). It also seems that 
quinpirole induced more calls from the accumbens core than did the amphetamine (compare 
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Figure 18 and 19). Because the stereotaxic co-ordinates were chosen for the nucleus accumbens 
shell, there were too few localizations purely in the accumbens core. Therefore, statistics were 
impossible to perform to compare subdivisions of the nucleus accumbens (see Figures 18 & 19). 
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Discussion 
Quinpirole Dose Response 
The low dose of quinpirole that most effectively and significantly increased 50 kHz calls 
above saline levels was the 0.25 Ilg dose. The increase in the number of calls caused by the 0.12 
Ilg dose approached the significance level (Z = 1.83, P < .07). It is possible that with injections of 
low doses of quinpirole there is a very narrow range for induction of vocalization behaviour. 
Nonetheless, the increase in 50 kHz calls above saline levels by the 0.25 Ilg dose was found in 
every group in which it was administered, indicating a reliable and reproducible finding. 
Similarly, 7 Ilg of amphetamine (positive control) also significantly increased 50 kHz 
calls above saline levels in each group in which it was administered. It has been well established 
throughout the literature that amphetamine elicits these calls after intraaccumbens application 
(Burgdorf et al., 2001; Thompson et al., 2006; Burgdorf, et al., 2007; Ahrens et at, 2009). The 
dosage of 7 Ilg was used because it had been shown to be an optimal dose in previous studies 
(Thompson et at, 2006). The magnitude of the amphetamine-induced response was comparable 
to that after 0.25 Ilg of quinpirole. 
The original hypothesis regarding the dose response before beginning this study was that 
there would be no significant increase in 50 kHz calls after low dose application of quinpirole. 
However, as demonstrated in the results section, this hypothesis was not supported. The 0.25 Ilg 
dose of quinpirole repeatedly demonstrated a significant increase in the 50 kHz calling response 
above saline levels. 
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Delayed Quinpirole Response 
Dose response groups were also used to analyze potential delayed quinpirole effects. It 
was found that when rats' USVs were recorded 35 - 40 minutes after the injection of drug, the 50 
kHz call response was significantly decreased in groups that initially had increased call 
responses (0.25 ~g quinpirole and 7 ~g amphetamine) when compared to saline groups. In 
systemic quinpirole injection studies looking at locomotor behaviour, biphasic effects in 
quinpirole's action were found (Szechtman et al., 1994; Culver, et aI., 2008). It was of interest to 
determine ifbiphasic effects would also be observed with respect to 50 kHz calling rates after 
intracerebral application of quinpirole. This was not the case; effects were observed immediately 
after injection and were not long lasting as seen by the decrease in calling over time (35 - 40 
minutes) for all sites and injection groups. 
Double Injections- Dopamine D2 and D3 receptor Antagonism 
Rats given a single saline intracerebral injection compared to those given a double 
intracerebral injection of saline did not differ significantly in the number of 50 kHz calls emitted 
(p < .17). This indicates that the double injection was not responsible for the increase in calling 
seen later from quinpirole and amphetamine. Similar to the single injections of 0.25 ~g 
quinpirole, and 7 ~g amphetamine, pre-treatment with saline followed by these agonists, again, 
elicited significantly more 50 kHz calls when compared to the double injection of saline. Saline 
injection did not change this response. When 0.25 ~g of quinpirole was pre-treated with an 
equimolar dose of raclopride, a D2 dopaminergic antagonist, the 50 kHz call response was not 
significantly affected. This indicates that quinpirole was perhaps exerting its actions using the D3 
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dopamine receptor type and not the D2 receptor type as previously hypothesized. In contrast, the 
50 kHz call response induced by the 7 ~g dose of amphetamine was significantly decreased by 
an equimolar pre-treatment with raclopride, confirming involvement of D2 dopamine receptors 
(Thompson et aI., 2006). The hypothesis constructed at the start of this thesis was that 
quinpirole's effects should be attenuated by the D2 antagonist raclopride because this was the 
case with work previously accomplished in our lab (St. Pierre, 2008). This hypothesis was 
defeated; which led to a new hypothesis that at low doses, quinpirole must work through action 
at another receptor, presumably the D3 receptor subtype. 
To investigate the lack of antagonism of the quinpirole response by raclopride, two more 
groups of rats were used to examine the dopaminergic receptor involved in the observed 
vocalization response. Since quinpirole is known to be a D2 and a D3 dopaminergic agonist, it is 
likely that, if the 50 kHz call response was not effectively antagonized by means of a D2 
dopaminergic antagonist (raclopride), then it should be antagonized by a D3 antagonist. Indeed 
this was the case. When rats were pre-treated with U-99194A maleate, a specific D3 
dopaminergic antagonist, there was a significant decrease in 50 kHz calls when compared to 
those elicited by injection of 0.25 ~g of quinpirole pre-treated with saline. The D3 dopamine 
receptor has not previously been implicated in the production of 50 kHz calls. There is evidence 
that Dl and D2 dopamine receptors in the nucleus accumbens shell can increase the amount of 50 
kHz calling when activated (Ranaldi & Beninger, 1994; Burgdorf et aI., 2001; Thompson et aI., 
2006; Burgdorf et aI., 2007). Because the D3 receptor subtype is also present in the mesolimbic 
DA system and is a member of the D2-like receptor family (Sokoloff et aI., 1990; Gehret et aI., 
1992; Neve & Neve 1997; Webster, 2001; Von Bohlen, et aI., 2002), it is plausible that this 
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receptor can exert similar effects when activated by quinpirole at the 0.25 J..lg dose. This result is 
the first evidence that the activation of the D3 dopaminergic receptor type in the nucleus 
accumbens can elicit 50 kHz calls and confirmed the hypothesis that quinpirole may work at the 
D3 dopamine receI?tor subtype. 
Proposed Mechanism of Action for Quinpirole 
The dose found to be the most effective at eliciting 50 kHz calls from the accumbens 
shell was the 0.25 J..lg dose; an effect reproduced many times in this thesis. Perhaps this dose of 
quinpirole was minimal enough to stimulate the D3 post-synaptic receptors without autoreceptor 
activation. Autoreceptors are responsible for auto-inhibition of a neuron's transmitter release by 
dampening DA synthesis and release (Elsworth & Roth, 1997; Von Bohlen, et aI., 2002; Cooper, 
et al. , 2003). It has been found that both D2 and D3 dopamine receptors in the nucleus accumbens 
have post-synaptic receptors and autoreceptors on pre-synaptic neurons (Sokoloff et aI., 1990; 
Gehret et aI., 1992; Neve & Neve, 1997; Elsworth & Roth, 1997; Webster, 2001; Cooper, et aI., 
2003). A threshold for autoreceptor activation has been suggested (Webster, 2001), and 
quinpirole could act at the post-synaptic site and remain at the sub-threshold dose for the pre-
synaptic autoreceptors. For dosages smaller than 0.25 J..lg (0.025 J..lg, 0.06 J..lg, 0.12 J..lg), the 
amount of drug could be simply not sufficient to elicit a response from the post-synaptic 
receptors (sub-threshold for post-synaptic response). The dosages higher than 0.25 J..lg quinpirole 
(0.5 J..lg & 1.0 J..lg), may have reached the threshold for autoreceptor activation, initiating a 
negative feedback loop subsequently decreasing the amount ofDA release from pre-synaptic 
neurons available for post-synaptic activation in the synapse and subsequently decreasing the 
number of emitted calls. For example, in an experiment completed by Wu et al., (1993), it was 
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found that a 4 ~g / 0.2 ~L injection of quinpirole into the nucleus accumbens significantly 
decreased the amount of locomotor behaviour observed. It was suggested that this inhibition of 
activity was due to autoreceptor activation. Also, as previously mentioned in the introduction, 
there has been evidence of autoreceptor activation being the cause of the initial decrease in 
locomotor behaviour being seen following acute systemic injections of quinpirole (Koller et aI., 
1987; Mogenson & Wu, 1991a; 1991b; Wu et aI., 1993; Neve & Neve, 1997; Lomanowska, et 
aI.,2004). 
Other work completed at Brock University (St. Pierre, 2008) suggests that once reaching 
higher doses of quinpirole, there are again significant increases in 50 kHz calls. At higher 
dosages, the synapses are most likely overwhelmed with the influx of agonist that even with 
autoreceptor activation, D2 and/or D3 post-synaptic activation is sufficient and thus gives an 
increase in 50 kHz calls. Also, there may be autoreceptor desensitization (Elsworth & Roth, 
1997; Von Bohlen, et aI., 2002; Cooper et al., 2003) resulting in even more post-synaptic 
stimulation and a subsequent increase in calls. It seems clear that quinpirole has action at pre-
synaptic as well as post-synaptic dopamine receptor sites. This differential affinity could be the 
cause of the narrow dose range found in this thesis as well as the supposed bi-modal effects of 
quinpirole on 50 kHz vocalization behaviour. 
Higher doses of quinpirole are antagonized by the D2 antagonist raclopride as found in 
our lab (St. Pierre, 2008). In this thesis, low doses of quinpirole are not antagonized by 
raclopride but rather the D3 antagonist U-99194A maleate. It has been suggested that quinpirole 
has a higher affinity for the D3 receptor type (Sokoloff et al., 1990; Gehret et al., 1992; Neve & 
Neve, 1997; Cooper et aI., 2003), making it likely that low doses preferentially bind with D3 
receptors over the D2 receptor type. The results from this thesis support the conclusion that 
quinpirole has a higher affinity for the D3 receptor sub-type; however, further speculation into 
the mechanism of fiction of quinpirole is beyond the scope of the data of this thesis. 
Sub-categorization of call types 
50 
There may be a shift in understanding the biological role of 50 kHz calls. Previous 
research suggested that all types of 50 kHz calls are associated with positive affective states in 
rats (Bialy et al., 2000; Burgdorf, et al., 2007; 2008; Brudzynski & Pniak, 2002; Brudzynski, 
2005; 2007). More recent papers have proposed that perhaps all types of 50 kHz calls may not 
directly express positive affective states (Wahr et aI., 2008; Ahrens et aI., 2009). However, 
current research is showing that flat 50 kHz calls may indicate social ambivalence or they may 
have a social co-ordinating function that may be associated with aggressive social contacts i.e., 
emitted as a means of ending an attack from a conspecific (Burgdorf et al., 2008; Wahr et aI., 
2008; Ahrens et aI., 2009). Whereas, the frequency modulated subtype of 50 kHz calls is where 
the expression of positive affect is found (Burgdorf et aI., 2008; Ahrens et aI., 2009). Panksepp 
and Burgdorf (2000; 2003) hypothesize that there is some "evolutionarily preserved correlate" 
between the frequency-modulated calls of rats and human laughter or joy. Both the 0.25 f..lg dose 
of quinpirole and the 7 f..lg dose of amphetamine not only significantly increased 50 kHz calls 
overall, but both dosages significantly increased the frequency modulated type of call. It is 
therefore plausible, based on the newly emerging hypotheses on 50 kHz vocalizations, that these 
drugs increase positive affect in these rats. By separating 50 kHz calls into subcategories, it can 
be said that all of the previous literature is in part, correct, if we are looking at the appropriate 
type of 50 kHz call. In a paper by W5hr et al., (2008) it was suggested that perhaps the 
, separation of 50 kHz calls into distinct sub-categories may draw some human parallels. For 
example, in hum~s, there is an unfelt social smile used as a communicative gesture in social 
situations (perhaps akin to the flat 50 kHz call?), and the Duchene smile, one that is affectively 
truthful (akin to the frequency modulated variety of calls?). 
The hypothesis constructed based on sonographic structure was much like that for 
amphetamine (Burgdorf et aI., 2001; Ahrens et al., 2009). If there was a significant increase in 
calls produced by a low dose of quinpirole, there should be a significant increase in the 
frequency modulated call type. This hypothesis was confirmed by the results of the thesis. It 
appeared that irrespective of whether non-selective (amphetamine) or selective (quinpirole) 
dopaminergic agonists were used, an increase in the frequency modulated type of 50 kHz calls 
was observed. 
Standard Call Parameters 
All mean call duration and mean peak frequency values obtained in this study, did not 
show significant differences among groups or drug conditions. The mean values observed were 
within the accepted range for a typical 50 kHz call type, i.e., within 35-70 kHz mean peak 
frequency and 3-65 ms in duration (Sales, 1972a; Blanchard et al., 1991; Brudzynski & Pniak, 
2002; Brudzynski, 2009). Interestingly, mean call bandwidth was affected by drug condition in 
the radopride antagonism group. An injection of 0.25 Ilg quinpirole following pre-treatment 
with saline showed a significant increase in call bandwidth (see Figure 9). This is not a 
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surprising result as it is likely explained by the increase in frequency modulated vocalizations 
elicited by the 0.25 Jlg dose of quinpirole. Bandwidth is measured by taking the maximum call 
frequency obtained and subtracting the minimum call frequency obtained (Brudzynski, 2009). 
Frequency modul~ted calls are characterized by increased bandwidth values. When comparing 
the injections of amphetamine pre-treated with saline or raclopride, mean call bandwidth was 
significantly decreased after raclopride pre-treatment (see Figure 9). If frequency modulation is 
decreasing, bandwidth decreases as well; it is a positively associated relationship. This result 
suggests that the frequency modulated calls disappeared after antagonizing the amphetamine 
response with raclopride. 
Localization of Intracerebral Injections 
Localization of injections for both the dose response and double injection groups were 
concentrated between the 10.7 - 9.7 mm from lambda based on the atlas by Paxinos and Watson 
(1986). This localization places the majority of injections in the medial portion ofthe nucleus 
accumbens shell (see Figures 16 & 17). It has been well established that the most robust 
emission of 50 kHz vocalizations occurs after psycho stimulant application to the medial shell 
(Thompson et aI., 2006; Sellings et aI., 2008; Ahrens et al., 2009). There have been a few studies 
on the anatomical localization within the accumbens relating to aversive responses and appetitive 
responses. The studies agree that stimulation in the rostral-medial shell results in appetitive 
behavioural responses, (i.e., increases in eating); whereas caudal shell stimulation results in 
aversion related responses, i.e., defensive treading and burying (Reynolds & Berridge, 2001; 
Faure et aI., 2008; Sellings et aI., 2008). 
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The nucleus accumbens has a distinct separation into the core and the shell regions 
(Mogenson & Wu, 1991a; Sellings et aI., 2008). The core region is connected to motor circuits 
whereas the shell is connected to limbic circuits (Mogenson & Wu, 1991a). It has been proposed 
that there is an int~gration of information between the two sections in that emotionally or 
motivationally salient information is assessed in the limbic regions and is then transferred to 
motor or behavioural output parts through motor circuits (Mogenson & Wu, 1991a). In a paper 
by Sellings et aI., (2008) it is explained as though the limbic regions are guiding behavioural 
responses based on positive or negative reinforcers. Based on this functional separation, it seems 
acceptable that if 50 kHz calls are an index of emotionality in rats, the calls should be elicited 
moreso from the shell than the core. This has been demonstrated in the past (Thompson et aI., 
2006), and is somewhat demonstrated in this thesis - due to a low N number for injection site 
localization within the core of the accumbens, proper statistical analysis could not be performed. 
However, when analyzing the data without statistics, it is apparent that the highest rates 50 kHz 
vocalizations are emitted after intraaccumbens injection in the shell region (See Figures 18 & 
19). 
Limitations and Variability in Data 
There has been a vast inter-individual variability in call production observed repeatedly 
with regard to call emission (Knutson et aI., 1998; Burgdorf & Panksepp, 2001; Wintink & 
Brudzysnki, 2001; Burgdorf & Panksepp, 2006; Schwarting et aI., 2007). Some rats may have a 
disposition to call more. In tests conducted by Wohr et aI., (2008), it was found that there was 
inter-individual variability not only in call emission but also within the standard call parameters 
of bandwidth, peak frequency, and call duration. Schwarting et aI., (2007) suggested that such 
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variability in individual results could be due to dispositions or traits that are characteristic to the 
subject under study. There have been studies in which rats were bred into three separate lines 
based on their propensity to call in the 50 kHz range (Burgdorf et aI., 2005; Harmon et aI., 2008; 
Burgdorf et aI., 20P8b). From these studies, it has been deduced that there may be a genetic 
predisposition to the amount of 50 kHz calls or the magnitude of positive emotion the rats 
express. The analysis of calls throughout this thesis supports the findings of considerable inter-
individual variability in calls. This type of variability is also consistent with work completed by 
W5hr et aI., (2008) where it was found that when comparing Long-Evans rats with Wistar rats, 
there was more individual variability and call rate variability in the Wistar strain (the strain used 
in this thesis). This inter-individual variability is the reason for the non-parametric statistical 
testing used throughout this thesis as normality in the distribution was not possible. 
In pharmacological studies with humans, it has been found that the dose of a drug that 
produces a specific response varies among patients. It is known that in any population of 
individuals, there will be a few that are remarkably sensitive to even low doses of drug, or in 
juxtaposition, are extremely tolerant to the drug (Julien, 2005). In light of this variability, many 
participants are required (larger N) to maximize the generalization of any drug's effects. This 
was a limitation in this study. Smaller group sizes of rats did not allow much room for error or 
extreme individual variance. 
Another possible problem lies in call fragmentation; which happens when long calls are 
emitted at a low air pressure and the rat loses the sound (Brudzynski, 2009). The ability to 
recognize two sounds as either separate vocalizations or two fragments of one call comes only 
with experience (Brudzynski, 2009). Throughout this thesis, the vocalization analysis was 
handled by one experimenter so as to eliminate any unreliability or bias across different 
, experimenters. Since 50 kHz calls have a very short duration, fragmentation of calls is most 
probably not a factor in this study. 
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In work completed by Natusch and Schwarting (20 I 0), it was found that environmental 
testing conditions are critical for 50 kHz vocalization recording. They observed that using fresh 
bedding in recording cages increased the number of 50 kHz vocalizations in all drug injection 
conditions, and this effect did not significantly decrease over test days. Although fresh bedding 
was used for each rat in this study, it was consistent across groups and drug conditions, and was 
done for every recording session, therefore it is unlikely that the observations made with regard 
to an increase in calls for both 0.25 /lg of quinpirole and 7 /lg of amphetamine are affected by 
bedding. In fact, it may enhance the finding that low doses of quinpirole other than the 0.25 /lg 
dose had no effect on vocalization behaviour if the fresh bedding used during those recording 
sessions was unable to increase 50 kHz calls above saline levels. If fresh bedding was to increase 
50 kHz calls in this case, it would have increased the magnitude of calls across all drug 
conditions because fresh bedding was used for each rat in each recording session. The work 
completed by N atusch and Schwarting (2010) is further evidence that environmental testing 
conditions when recording affective behaviours are important and are something that needs to be 
controlled for as best as possible. 
Future Directions 
Future research should look at the possibility of antagonizing the 50 kHz call response 
elicited by high doses of quinpirole using U-99194A maleate. Also, a D21D3 receptor antagonist 
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"cocktail" could be injected as a pre-treatment to an optimal high dose of quinpirole which 
should then completely abolish calling rates. Also, using selective D2 and/or D3 autoreceptor 
antagonists may prove helpful in shaping a more exact mechanism of action at the receptor level 
for quinpirole. 
With respect to 50 kHz vocalizations, much research is needed to look into the further 
sub-categorization of 50 kHz calls. Recent work completed by Wright et al., (2010) separated 50 
kHz calls into fourteen sub-categories based on sonographic structure; however, to be useful for 
future research with respect to positive affective states, calls should be sub-categorized based on 
biological function. The work completed by Wright, et aI., (2010) is encouraging because the 
calls with different sonographic structure that were categorized as "frequency-modulated other" 
in this thesis can possibly be further separated based on their functionality now that the possible 
categories have been defined. By accomplishing that task, it may aid in addiction, emotional, and 
motivational disorder research by allowing various types of drugs of abuse to be studied further 
based on the effects they have on emotion and motivation. 
Conclusions 
It is clear that quinpirole in the low dose range is acting at the D3 receptor subtype, 
indicating that the D3 dopamine receptor in the nucleus accumbens medial shell also contributes 
to 50 kHz vocalization behaviour. Also, low doses of quinpirole seem to be increasing positive 
affective states in the rat because the 0.25 ~g dose significantly increased the frequency 
modulated type of 50 kHz calls, which are known to indicate an increase in positive affective 
states in rats (Panksepp & Burgdorf, 2000; 2003, Burgdorf et aI., 2008; Ahrens et aI., 2009). To 
my knowledge, this is the first report of D3 receptor involvement in 50 kHz USV production. 
Perhaps further research into the mechanisms underlying quinpirole's actions could help with a 
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, better understanding of emotional and motivational states in rats and may contribute to an animal 
model of emotional disorders with the ultimate goal being to better the lives of humans suffering 
from this type of abnormality. 
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Figure 1. Full dose response for quinpirole at low doses (0.025 flg, 0.06 flg, 0.12 flg, 0.25 flg, 0.5 flg, and 1.0 flg) along 
with saline and the 7 flg amphetamine controls. The y-axis shows the mean number of 50 kHz vocalizations in ten 
minutes of recording. Error bars represent SEM. * indicates significance level p <0.05 ** indicates significance level 
p<.Ol 
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Figure 2. Mean number of 50 kHz calls within 10 minutes (groups 1 and 2) with statistical analyses. Saline and 7 /lg 
amphetamine controls along with the 0.25 J.lg and 0.5 /lg dosages of quinpirole. Statistical analyses were completed using 
the non-parametric Friedman ANOV A followed by the non-parametric Wilcoxon Signed Ranks Test. 
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Figure 3. Mean number of 50 kHz calls within 10 minutes immediately following intracerebral injection and 40 minutes 
later with no additional injection. Statistical analyses were completed using the non-parametric Friedman ANOV A 
followed by the non-parametric Wilcoxon Signed Ranks Test. Error bars represent SEM. * indicates significance level p 
<0.05 ** indicates significance level p <.01 
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Figure 4. Mean number of 50 kHz calls in 10 minutes after double injections: pre-treatment with saline or D2 antagonist 
raclopride. Psychostimulants used were 0.25 Jlg of quinpirole and 7 Jlg of amphetamine. Due to a relatively low N number 
of 11 rats, and the amount of inter-individual variability, sal-amph compared to rac-amph was not quite statistically 
significant although it was approaching significance (p < 0.07). Comparing rac-quin and rac-amph the D2 antagonist 
response observed is not similar. Statistical analyses were completed using the non-parametric Friedman ANOV A 
followed by the non-parametric Wilcoxon Signed Ranks Test. Error bars represent SEM. * indicates significance level p 
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Figure 5. Mean number of 50 kHz calls in 10 minutes after unilateral double injections: pre-treatment with saline or D3 
antagonist U99194A maleate (equimolar to 0.25 flg quinpirole) followed by 0.25 flg quinpirole. Statistical analyses were 
completed using the non-parametric Friedman ANOV A followed by the non-parametric Wilcoxon Signed Ranks Test. 
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Figure 6. Mean call bandwidth and mean call peak frequencies (in kHz) of dose response groups (saline, 0.25 J.Lg 
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Figure 7. Mean call duration (in seconds) of dose response groups (saline, 0.25 Ilg quinpirole, 0.5 Ilg quinpirole, 7 Ilg 
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Figure 8. Mean call peak frequencies (in kHz) ofD2 antagonist double injection group using 0.25 J,lg quinpirole and 7 J,lg 
amphetamine. Error bars represent SEM. 
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Figure 9. Mean call bandwidth (in kHz) ofD2 antagonist double injection group using 0.25 Ilg quinpirole and 7 Ilg 
amphetamine. Statistical analyses were completed using the non-parametric Friedman ANOV A followed by the non-
parametric Wilcoxon Signed Ranks Test. Error bars represent SEM. * indicates significance level p <0.05 
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Figure 10. Mean call duration (in seconds) ofD2 antagonist double injection group using 0.25 Ilg quinpirole and 7 Ilg 
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Figure 11. Mean call bandwidth and mean call peak frequencies (in kHz) ofD3 antagonist group using 0.25 J.1g quinpiroie 
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umal-quin 
Figure 12. Mean call duration (in seconds) ofD3 antagonist group using 0.25 flg quinpirole and 7 flg amphetamine. Error 
bars represent SEM. 
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Figure 13. Total numbers of sonographic call types (listed on margin) observed in each drug condition for dose response 
groups used for statistical analysis (saline, 0.25 Ilg quinpirole, 0.5 Ilg quinpirole, 7 Ilg amphetamine). Statistical analyses 
were completed using the non-parametric Friedman ANOV A followed by the non-parametric Wilcoxon Signed Ranks 
Test. * indicates significance level p <0.05 ** indicates significance level p <.01 
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Figure 14. Total numbers of sonographic call types (listed on margin) observed in each drug condition for D2 antagonist 
double iJ1iections pre-treated with saline or rac10pride followed by the 0.25 Ilg dose of quinpirole or the 7 Ilg amphetamine 
dose. Statistical analyses were completed using the non-parametric Friedman ANOV A followed by the non-parametric 
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Double Injection Drug Condition 
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Figure 15. Total numbers of sonographic call types (listed on margin) observed in each drug condition for D3 antagonist 
double injections pre-treated with saline or U99194A maleate followed by the 0.25 /lg dose of quinpirole. Statistical 
analyses were completed using the non-parametric Friedman ANOV A followed by the non-parametric Wilcoxon Signed 
Ranks Test. * indicates significance level p <0.05 ** indicates significance level p <.01 
Figure 16. Anatomical localization of intracerebral injection sites for dose response groups (groups 1-3) on 
coronal sections from the atlas of Paxinos and Watson (1986). All injections were from 10.7-9.7 mm from 
lambda placing them in the medial nucleus accumbens shell. 
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List of Abbreviations: AcC = nucleus accumbens core, ac = anterior commissure, AcS = nucleus accumbens shell, CP = caudate 
putamen, LS = lateral septal nucleus, LV = lateral ventricle, mfb = medial forebrain bundle, VP = ventral pallidum, To = olfactory 
tubercule, on = optic nerve, DBb = nu horizontal limb diagonal band, DBv = nu vertical limb diagonal band, MS = medial septal 
nucleus 
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Figure 17. Anatomical localization of intracerebral injection sites for double injection groups (groups 4-6) on 
coronal sections from the atlas of Paxinos and Watson (1986). All injections were from 10.7-9.7 mm from 













0 30 til 
-0 
.. 










Accumbens localizations for 0.25 J,lg 
Quinpirole Response 
N=4 
core shell border of shell 
Nucleus Accumbens Localization 
Figure 18. Mapping of 50 kHz call magnitude elicited by 0.25 flg injections of quinpirole. A) Shows 
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localization of injection sites with symbols indicating the number of calls induced. B) Shows a summary of the 
mean number of calls per anatomical localization. Due to a small N number in the core localization, statistics 
were not able to be performed. However, it is apparent that the majority of high vocalizing rats were injected in 
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Figure 19. Mapping of 50 kHz call magnitude elicited by 7 Ilg injections of amphetamine. A) Shows 
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localization of injection sites with symbols indicating the number of calls induced. B) Shows a summary of the 
mean number of calls per anatomical localization. Due to a small N number in the core localization, statistics 
were not able to be performed. However, it is apparent that the majority of high vocalizing rats were injected in 
the nucleus accumbens shell. Error bars represent SEM. Refer to Figure 16 for abbreviations. 
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Figure 20. A few samples of different 50 kHz vocalizations elicited by 0.25 Ilg injection of 
quinpirole. Each figure includes a spectrogram (on the right hand side), and a power spectrum 
(on the left hand side). A) Flat 50 kHz vocalization B) Trill 50 kHz vocalization C) Step-tri1l50 
kHz vocalization D) FM other (frequency modulated other) 50 kHz vocalization. Frequency is in 
kHz, time is in ms, and power is on relative values. 
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Appendix A 
Quin = Quinpirole 
Amph = Amphetamine 
MWQ = male, wistar, quinpirole 
UMAL = U99194A Maleate 




Dose Response Groups Intracerebral Injection Schedule and Drug Dosage 
Rat 1.0. Injection 1- Injection 2 - Injection 3- Injection 4- Injection 5 -
Group #1 Right Cannula Right Cannula Right Cannula Right Cannula Left Cannula 
MWQl O.251lg Quin saline O.51lg Quin 1.0llg Quin 71lg Amph 
MWQ2 saline O.251lg Quin 1.01J.g Quin O.51lg Quin 71lg Amph 
MWQ3 O.251lg Quin saline O.51lg Quin 1.0llg Quin 71lg Amph 
MWQ4 saline O.251lg Quin 1.01J.g Quin O.51lg Quin 71lg Amph 
MWQ5 O.251lg Quin saline O.51lg Quin 1.0llg Quin 71lg Amph 
MWQ6 saline O.251lg Quin 1.01lg Quin O.51lg Quin 71lg Amph 
MWQ7 O.251lg Quin saline O.51lg Quin 1.01lg Quin 71lg Amph 
MWQ8 1.01lg Quin O.51lg Quin O.251lg Quin saline 71lg Amph 
MWQ9 O.51lg Quin 1.01lg Quin saline O.251lg Quin 71lg Amph 
MWQ10 1.01lg Quin O.51lg Quin O.251lg Quin saline 71lg Amph 
MWQll O.5llg Quin 1.01lg Quin saline O.251lg Quin 71lg Amph 
MWQ12 1.0llg Quin O.51lg Quin O.251lg Quin saline 71lg Amph 
MWQ13 O.5llg Quin 1.01lg Quin saline O.251lg Quin 71lg Amph 
MWQ14 1.0llg Quin O.51lg Quin O.251lg Quin saline 71lg Amph 
Group #2 Injection 1- Injection 2- Injection 3 - Injection 4- Injection 5-
Right Cannula Right Cannula Right Cannula Right Cannula Left Cannula 
MWQ15 saline O.251lg Quin O.121lg Quin O.51lg Quin 71lg Amph 
MWQ16 O.251lg Quin saline O.5llg Quin O.121lg Quin 71lg Amph 
MWQ17 saline O.251lg Quin O.121J.g Quin O.51lg Quin 71lg Amph 
MWQ18 O.251lg Quin saline O.5llg Quin O.121lg Quin 71lg Amph 
MWQ19 saline O.251lg Quin O.121lg Quin O.51lg Quin 71J.g Amph 
MWQ20 O.251lg Quin saline O.5llg Quin O.121lg Quin 71lg Amph 
MWQ21 saline O.251lg Quin O.121lg Quin O.5llg Quin 71lg Amph 
MWQ22 O.251lg Quin saline O.51lg Quin O.121lg Quin 71lg Amph 
MWQ23 O.121lg Quin O.51lg Quin O.251lg Quin saline 71lg Amph 
MWQ24 O.5llg Quin O.121lg Quin saline O.251J.g Quin 71lg Amph 
MWQ25 O.121lg Quin O.51lg Quin O.251lg Quin saline 71lg Amph 
MWQ26 O.51lg Quin O.121lg Quin saline O.251lg Quin 71J.g Amph 
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MWQ27 O.12lJ.gQuin O.51J.g Quin O.25lJ.gQuin saline 7IJ.g Amph 
MWQ28 O.51J.g Quin O.12lJ.gQuin saline O.25lJ.gQuin 7IJ.g Amph 
MWQ29 O.12lJ.gQuin O.51J.g Quin O.251J.g Quin saline 7IJ.g Amph 
MWQ30 O.51J.g Quin O.12lJ.gQuin saline 0.25lJ.gQuin 7IJ.g Amph 
Group #3 ~njection 1- Injection 2 - Injection 3 - Injection 4 -
Right Cannula Right Cannula Right Cannula Right Cannula 
MWQ31 saline 0.06 ugQuin 1.0 ug Quin 0.025 ug Quin 
MWQ32 0.06 ugQuin Saline 0.025 ug Quin 1.0 ug Quin 
MWQ33 saline 0.06 ugQuin 1.0 ug Quin 0.025 ug Quin 
MWQ34 0.06 ugQuin Saline 0.025 ug Quin 1.0 ug Quin 
MWQ35 Saline 0.06 ugQuin 1.0 ug Quin 0.025 ug Quin 
MWQ36 0.06 ugQuin Saline 0.025 ug Quin 1.0 ug Quin 
MWQ37 1.0 ug Quin 0.025 ug Quin Saline 0.06 ug Quin 
MWQ38 0.025 ug Quin 1.0 ug Quin 0.06 ug Quin Saline 
MWQ39 1.0 ug Quin 0.025 ug Quin Saline 0.06 ugQuin 
MWQ40 0.025 ug Quin 1.0 ug Quin 0.06 ugQuin Saline 
MWQ41 1.0 ug Quin 0.025 ug Quin Saline 0.06 ugQuin 
MWQ42 0.025 ug Quin 1.0 ug Quin 0.06 ug Quin saline 
Injection Schedule Group #4 - Double injections 
All QUIN = 0.25 Ilg dose of Quinpriole 
All RAC = equimolar dose of raclopride to either quinpirole or amphetamine 
All AMPH = 7 Ilg dose of amphetamine 
All UMAL (D3 antagonist) = dose equimolar to quinpirole 
Left Rat 43,50' Rat 45, 46 Rat 47, 48 Rat 49 & Rat 51 & Rat 53 & 
Cannula &55 &56 &57 44 52 54 
Injection 1 SAL RAC SAL SAL RAC SAL 
QUIN QUIN SAL SAL QUIN QUIN 
Injection 3 RAC SAL SAL RAC SAL SAL 
QUIN QUIN QUIN QUIN SAL SAL 
Injection 5 SAL SAL RAC SAL SAL RAC 
SAL SAL QUIN QUIN QUIN QUIN 
Right Rat 43,50 & Rat 45, 46 & Rat 47,48 Rat 49 & 44 Rat 51 & 52 
Cannula 55 56 &57 
Injection 2 SAL-AM PH RAC-AMPH SAL -RAC SAL-RAC RAC-AMPH 
Injection 4 RAC-AMPH SAL-AM PH SAL-AM PH RAC-AMPH SAL-RAC 
Injection 6 SAL-RAC SAL-RAC RAC-AMPH SAL-AM PH SAL-AMPH 
Group 5 Injection Plan 
Right Cannula Rat 58, 63, 68, Rat 59, 64, 69 Rat 60,65, 70 Rat 61, 66, 71 
73 
Injection 1 SAL-UMAL UMAL-QUIN SAL-QUIN SAL-SAL 
Injection 3 UMAL-QUIN SAL-UMAL SAL-SAL UMAL-QUIN 
Left Cannula Rat 58, 63, 68, Rat 59,64,69 Rat 60, 65, 70 Rat 61, 66, 71 
73 
Injection 2 SAL-QUIN SAL-SAL UMAL-QUIN SAL-UMAL 
Injection 4 SAL-SAL SAL-QUIN SAL-UMAL SAL-QUIN 
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Rat 62, 67, 72 
SAL-UMAL 
SAL-QUIN 




Group 6 Injection Plan 
Right Cannula Rat 74, 75, 82 Rat 76, 77, 83 Rat 78, 79, 84 Rat 80, 81, 85 
Injection 1 SAL-UMAL SAL-SAL UMAL-QUIN SAL-QUIN 
Injection 3 SAL-SAL SAL-UMAL SAL-QUIN UMAL-QUIN 
Left Cannula Rat 74, 75, 82 Rat 76, 77, 83 Rat 78, 79, 84 Rat 80, 81, 85 
Injection 2 UMAL-QUIN SAL-QUIN SAL-SAL SAL-UMAL 
Injection 4 SAL-QUIN UMAL-QUIN SAL-UMAL SAL-SAL 
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